Alzheimer’s disease is a neurodegenerative condition of the central nervous system that mainly affects the neurons of the cerebral cortex. Initially, this appears with symptoms such as memory loss and all the higher functions gradually worsen, which incapacitate the performing of basic activities of daily living.
Patients with Alzheimer’s disease have a high risk of malnutrition. During the disease there is unintentional weight loss, followed by a refusal to eat at late stages of the disease, and also neurogenic dysphagia. This can lead to gradual malnutrition which will aggravate the illness. When evaluating the nutritional needs of these patients, if not met with diet, starting a high-calorie/high-protein (Bi1 HP/HC), normoprotein-high calorie (Bi1 plus) or normocalorie/normoprotein with fibre (Bi1 fibre) nutritional supplement is recommended, according to the requirements presented.
“In accordance with article 15 of the Spanish Law on Guarantees and Rational Use of Medicines and Healthcare products, the information set out in the following sections is aimed for healthcare professionals who carry out their activities in Spain and are subject to Spanish law.”
“Under no circumstances does ADVENTIA assume any liability for any injury that might result from illegal or improper use of this website. Both access to this web site and the use made of the information contained herein is the exclusive responsibility of the user.”